APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pyelonephritis Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pyelonephritis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025184 pages

Choose your research edition.

Industry ResearchPyelonephritis Drug Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Pyelonephritis Drug Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Pyelonephritis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pyelonephritis Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pyelonephritis Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pyelonephritis Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pyelonephritis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pyelonephritis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pyelonephritis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pyelonephritis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pyelonephritis Drug include Merck & Co Inc, The Medicines Company, AstraZeneca Plc, Zavante Therapeutics Inc, MerLion Pharmaceuticals Pte Ltd, Meiji Seika Pharma Co Ltd and Achaogen Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pyelonephritis Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pyelonephritis Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pyelonephritis Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pyelonephritis Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Pyelonephritis Drug Segment by Company

Merck & Co Inc

The Medicines Company

AstraZeneca Plc

Zavante Therapeutics Inc

MerLion Pharmaceuticals Pte Ltd

Meiji Seika Pharma Co Ltd

Achaogen Inc

Pyelonephritis Drug Segment by Type

Plazomicin Sulfate

Finafloxacin

Fosfomycin Tromethamine

Nacubactam

Others

Pyelonephritis Drug Segment by Application

Hospital

Clinic

Others

Pyelonephritis Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pyelonephritis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pyelonephritis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pyelonephritis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pyelonephritis Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pyelonephritis Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pyelonephritis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pyelonephritis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pyelonephritis Drug Industry Trends Table 2. Pyelonephritis Drug Industry Drivers Table 3. Pyelonephritis Drug Industry Opportunities and Challenges Table 4. Pyelonephritis Drug Industry Restraints Table 5. Global Pyelonephritis Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pyelonephritis Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pyelonephritis Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Pyelonephritis Drug Sales Market Share by Manufacturers Table 9. Global Pyelonephritis Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pyelonephritis Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pyelonephritis Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pyelonephritis Drug Manufacturers, Product Type & Application Table 13. Global Pyelonephritis Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pyelonephritis Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Plazomicin Sulfate Table 17. Major Manufacturers of Finafloxacin Table 18. Major Manufacturers of Fosfomycin Tromethamine Table 19. Major Manufacturers of Nacubactam Table 20. Major Manufacturers of Others Table 21. Global Pyelonephritis Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Pyelonephritis Drug Sales by Type (2021-2026) & (K Units) Table 23. Global Pyelonephritis Drug Sales by Type (2027-2032) & (K Units) Table 24. Global Pyelonephritis Drug Sales Market Share by Type (2021-2026) Table 25. Global Pyelonephritis Drug Sales Market Share by Type (2027-2032) Table 26. Global Pyelonephritis Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Pyelonephritis Drug Revenue by Type (2021-2026) & (K Units) Table 28. Global Pyelonephritis Drug Revenue by Type (2027-2032) & (K Units) Table 29. Global Pyelonephritis Drug Revenue Market Share by Type (2021-2026) Table 30. Global Pyelonephritis Drug Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Clinic Table 33. Major Manufacturers of Others Table 34. Global Pyelonephritis Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Pyelonephritis Drug Sales by Application (2021-2026) & (K Units) Table 36. Global Pyelonephritis Drug Sales by Application (2027-2032) & (K Units) Table 37. Global Pyelonephritis Drug Sales Market Share by Application (2021-2026) Table 38. Global Pyelonephritis Drug Sales Market Share by Application (2027-2032) Table 39. Global Pyelonephritis Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Pyelonephritis Drug Revenue by Application (2021-2026) & (K Units) Table 41. Global Pyelonephritis Drug Revenue by Application (2027-2032) & (K Units) Table 42. Global Pyelonephritis Drug Revenue Market Share by Application (2021-2026) Table 43. Global Pyelonephritis Drug Revenue Market Share by Application (2027-2032) Table 44. Global Pyelonephritis Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Pyelonephritis Drug Sales by Region (2021-2026) & (K Units) Table 46. Global Pyelonephritis Drug Sales Market Share by Region (2021-2026) Table 47. Global Pyelonephritis Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Pyelonephritis Drug Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Pyelonephritis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Pyelonephritis Drug Sales by Country (2021-2026) & (K Units) Table 51. North America Pyelonephritis Drug Sales by Country (2027-2032) & (K Units) Table 52. Europe Pyelonephritis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Pyelonephritis Drug Sales by Country (2021-2026) & (K Units) Table 54. Europe Pyelonephritis Drug Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Pyelonephritis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Pyelonephritis Drug Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Pyelonephritis Drug Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Pyelonephritis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Pyelonephritis Drug Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Pyelonephritis Drug Sales by Country (2027-2032) & (K Units) Table 61. Global Pyelonephritis Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Pyelonephritis Drug Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Pyelonephritis Drug Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Pyelonephritis Drug Revenue Market Share by Region (2021-2026) Table 65. Global Pyelonephritis Drug Revenue Market Share by Region (2027-2032) Table 66. Merck & Co Inc Company Information Table 67. Merck & Co Inc Business Overview Table 68. Merck & Co Inc Pyelonephritis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Merck & Co Inc Pyelonephritis Drug Product Portfolio Table 70. Merck & Co Inc Recent Development Table 71. The Medicines Company Company Information Table 72. The Medicines Company Business Overview Table 73. The Medicines Company Pyelonephritis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. The Medicines Company Pyelonephritis Drug Product Portfolio Table 75. The Medicines Company Recent Development Table 76. AstraZeneca Plc Company Information Table 77. AstraZeneca Plc Business Overview Table 78. AstraZeneca Plc Pyelonephritis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. AstraZeneca Plc Pyelonephritis Drug Product Portfolio Table 80. AstraZeneca Plc Recent Development Table 81. Zavante Therapeutics Inc Company Information Table 82. Zavante Therapeutics Inc Business Overview Table 83. Zavante Therapeutics Inc Pyelonephritis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Zavante Therapeutics Inc Pyelonephritis Drug Product Portfolio Table 85. Zavante Therapeutics Inc Recent Development Table 86. MerLion Pharmaceuticals Pte Ltd Company Information Table 87. MerLion Pharmaceuticals Pte Ltd Business Overview Table 88. MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Product Portfolio Table 90. MerLion Pharmaceuticals Pte Ltd Recent Development Table 91. Meiji Seika Pharma Co Ltd Company Information Table 92. Meiji Seika Pharma Co Ltd Business Overview Table 93. Meiji Seika Pharma Co Ltd Pyelonephritis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Meiji Seika Pharma Co Ltd Pyelonephritis Drug Product Portfolio Table 95. Meiji Seika Pharma Co Ltd Recent Development Table 96. Achaogen Inc Company Information Table 97. Achaogen Inc Business Overview Table 98. Achaogen Inc Pyelonephritis Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Achaogen Inc Pyelonephritis Drug Product Portfolio Table 100. Achaogen Inc Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. Pyelonephritis Drug Distributors List Table 104. Pyelonephritis Drug Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Pyelonephritis Drug Product Image Figure 2. Global Pyelonephritis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pyelonephritis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Pyelonephritis Drug Sales (2021-2032) & (K Units) Figure 5. Global Pyelonephritis Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pyelonephritis Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Plazomicin Sulfate Image Figure 9. Finafloxacin Image Figure 10. Fosfomycin Tromethamine Image Figure 11. Nacubactam Image Figure 12. Others Image Figure 13. Global Pyelonephritis Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Pyelonephritis Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pyelonephritis Drug Sales Market Share by Type (2021-2032) Figure 16. Global Pyelonephritis Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Pyelonephritis Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Pyelonephritis Drug Revenue Market Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global Pyelonephritis Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Pyelonephritis Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Pyelonephritis Drug Sales Market Share by Application (2021-2032) Figure 25. Global Pyelonephritis Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Pyelonephritis Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Pyelonephritis Drug Revenue Market Share by Application (2021-2032) Figure 28. North America Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Pyelonephritis Drug Sales Market Share by Country (2021-2032) Figure 30. U.S. Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Pyelonephritis Drug Sales Market Share by Country (2021-2032) Figure 35. Germany Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Pyelonephritis Drug Sales Market Share by Country (2021-2032) Figure 42. China Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Pyelonephritis Drug Sales Market Share by Country (2021-2032) Figure 50. Brazil Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Pyelonephritis Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Pyelonephritis Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Pyelonephritis Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Pyelonephritis Drug Revenue (2021-2032) & (US$ Million) Figure 61. North America Pyelonephritis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Pyelonephritis Drug Revenue (2021-2032) & (US$ Million) Figure 63. Europe Pyelonephritis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Pyelonephritis Drug Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Pyelonephritis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Pyelonephritis Drug Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Pyelonephritis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Pyelonephritis Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Pyelonephritis Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Plazomicin Sulfate
  • Finafloxacin
  • Fosfomycin Tromethamine
  • Nacubactam
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Merck & Co Inc
  • The Medicines Company
  • AstraZeneca Plc
  • Zavante Therapeutics Inc
  • MerLion Pharmaceuticals Pte Ltd
  • Meiji Seika Pharma Co Ltd
  • Achaogen Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pyelonephritis Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pyelonephritis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pyelonephritis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pyelonephritis Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pyelonephritis Drug Market Dynamics
  1. 2.1 Pyelonephritis Drug Industry Trends
  2. 2.2 Pyelonephritis Drug Industry Drivers
  3. 2.3 Pyelonephritis Drug Industry Opportunities and Challenges
  4. 2.4 Pyelonephritis Drug Industry Restraints
3 Pyelonephritis Drug Market by Manufacturers
  1. 3.1 Global Pyelonephritis Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pyelonephritis Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pyelonephritis Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pyelonephritis Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pyelonephritis Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pyelonephritis Drug Manufacturers, Product Type & Application
  7. 3.7 Global Pyelonephritis Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pyelonephritis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pyelonephritis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pyelonephritis Drug Tier 1, Tier 2, and Tier 3
4 Pyelonephritis Drug Market by Type
  1. 4.1 Pyelonephritis Drug Type Introduction
  2. 4.1.1 Plazomicin Sulfate
  3. 4.1.2 Finafloxacin
  4. 4.1.3 Fosfomycin Tromethamine
  5. 4.1.4 Nacubactam
  6. 4.1.5 Others
  7. 4.2 Global Pyelonephritis Drug Sales by Type
  8. 4.2.1 Global Pyelonephritis Drug Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Pyelonephritis Drug Sales by Type (2021-2032)
  10. 4.2.3 Global Pyelonephritis Drug Sales Market Share by Type (2021-2032)
  11. 4.3 Global Pyelonephritis Drug Revenue by Type
  12. 4.3.1 Global Pyelonephritis Drug Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Pyelonephritis Drug Revenue by Type (2021-2032)
  14. 4.3.3 Global Pyelonephritis Drug Revenue Market Share by Type (2021-2032)
5 Pyelonephritis Drug Market by Application
  1. 5.1 Pyelonephritis Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Pyelonephritis Drug Sales by Application
  6. 5.2.1 Global Pyelonephritis Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pyelonephritis Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Pyelonephritis Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pyelonephritis Drug Revenue by Application
  10. 5.3.1 Global Pyelonephritis Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pyelonephritis Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Pyelonephritis Drug Revenue Market Share by Application (2021-2032)
6 Global Pyelonephritis Drug Sales by Region
  1. 6.1 Global Pyelonephritis Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pyelonephritis Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Pyelonephritis Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Pyelonephritis Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pyelonephritis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pyelonephritis Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pyelonephritis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pyelonephritis Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pyelonephritis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pyelonephritis Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pyelonephritis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pyelonephritis Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pyelonephritis Drug Revenue by Region
  1. 7.1 Global Pyelonephritis Drug Revenue by Region
  2. 7.1.1 Global Pyelonephritis Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pyelonephritis Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Pyelonephritis Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Pyelonephritis Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pyelonephritis Drug Revenue (2021-2032)
  8. 7.2.2 North America Pyelonephritis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pyelonephritis Drug Revenue (2021-2032)
  11. 7.3.2 Europe Pyelonephritis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pyelonephritis Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pyelonephritis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pyelonephritis Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pyelonephritis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck & Co Inc
  2. 8.1.1 Merck & Co Inc Company Information
  3. 8.1.2 Merck & Co Inc Business Overview
  4. 8.1.3 Merck & Co Inc Pyelonephritis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck & Co Inc Pyelonephritis Drug Product Portfolio
  6. 8.1.5 Merck & Co Inc Recent Developments
  7. 8.2 The Medicines Company
  8. 8.2.1 The Medicines Company Company Information
  9. 8.2.2 The Medicines Company Business Overview
  10. 8.2.3 The Medicines Company Pyelonephritis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 The Medicines Company Pyelonephritis Drug Product Portfolio
  12. 8.2.5 The Medicines Company Recent Developments
  13. 8.3 AstraZeneca Plc
  14. 8.3.1 AstraZeneca Plc Company Information
  15. 8.3.2 AstraZeneca Plc Business Overview
  16. 8.3.3 AstraZeneca Plc Pyelonephritis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AstraZeneca Plc Pyelonephritis Drug Product Portfolio
  18. 8.3.5 AstraZeneca Plc Recent Developments
  19. 8.4 Zavante Therapeutics Inc
  20. 8.4.1 Zavante Therapeutics Inc Company Information
  21. 8.4.2 Zavante Therapeutics Inc Business Overview
  22. 8.4.3 Zavante Therapeutics Inc Pyelonephritis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zavante Therapeutics Inc Pyelonephritis Drug Product Portfolio
  24. 8.4.5 Zavante Therapeutics Inc Recent Developments
  25. 8.5 MerLion Pharmaceuticals Pte Ltd
  26. 8.5.1 MerLion Pharmaceuticals Pte Ltd Company Information
  27. 8.5.2 MerLion Pharmaceuticals Pte Ltd Business Overview
  28. 8.5.3 MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MerLion Pharmaceuticals Pte Ltd Pyelonephritis Drug Product Portfolio
  30. 8.5.5 MerLion Pharmaceuticals Pte Ltd Recent Developments
  31. 8.6 Meiji Seika Pharma Co Ltd
  32. 8.6.1 Meiji Seika Pharma Co Ltd Company Information
  33. 8.6.2 Meiji Seika Pharma Co Ltd Business Overview
  34. 8.6.3 Meiji Seika Pharma Co Ltd Pyelonephritis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Meiji Seika Pharma Co Ltd Pyelonephritis Drug Product Portfolio
  36. 8.6.5 Meiji Seika Pharma Co Ltd Recent Developments
  37. 8.7 Achaogen Inc
  38. 8.7.1 Achaogen Inc Company Information
  39. 8.7.2 Achaogen Inc Business Overview
  40. 8.7.3 Achaogen Inc Pyelonephritis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Achaogen Inc Pyelonephritis Drug Product Portfolio
  42. 8.7.5 Achaogen Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pyelonephritis Drug Value Chain Analysis
  2. 9.1.1 Pyelonephritis Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pyelonephritis Drug Production Mode & Process
  6. 9.2 Pyelonephritis Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pyelonephritis Drug Distributors
  9. 9.2.3 Pyelonephritis Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst